Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

By A. Vrieze, E. van Nood, F. Holleman, J. Salojärvi, R. Kootte, J. Bartelsman, G. Dallinga-Thie, M. Ackermans, M. Serlie, R. Oozeer and 11 more. Gastroenterology, 2012

2,745 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/5411af2c42dc2daa3bb298f0316c905f125092c2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Molecular Biology

In Physiology

Citations in the corpus

Impact of the gut microbiota on inflammation, obesity, and metabolic disease (2016, background): “insulin sensitivity after transplantation than nine men who received a transplant of their own stool [71].”
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut (2016, background): “…that fecal numbers in infants younger than 6 months are undetectable, slightly increase between the age of 6 and 24 months, then suddenly increase to reach a peak during late childhood and adolescence, and finally decrease again during adulthood and especially in the elderly (Miquel et al., 2014).”
The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota (2016, background): “Recently, the gut microbiota has gained great attention in metabolic diseases since gut dysbiosis has been demonstrated in obesity,((7,8)) MetS,((9,10)) diabetes,((11,12)) and cardiovascular diseases.”
Factors affecting the composition of the gut microbiota, and its modulation (2019, neutral): “, 2017), metabolic diseases (Tremaroli & Bäckhed, 2012; Tilg & Kaser, 2011; Vrieze et al., 2012), neuropsychiatric conditions (Hornig, 2013; He et al.”
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024, background): “…448 alleviate endothelial oxidative stress, 449 attenuate in ﬂ ammatory processes, 450 and foster a favorable balance of the gut microbiota, 451 all of which collectively contribute to the salutary effects of these agents in patients with AS. GLP-1RAs have been shown to exert bene ﬁ cial…”
Dysbiosis of the gut microbiota in disease (2015, background): “Two observations relevant to answering this question are one, that the transfer of microbiota from lean donors into individuals with metabolic syndrome can increase insulin sensitivity and overall amelioration of symptoms of metabolic disease (60) and two, dietary changes in humans leads to rapid an”